Congenital Heart Defects and 22q11.2 Deletion Syndrome: A 20-Year Update and New Insights to Aid Clinical Diagnosis

Abstract

Congenital heart defects (CHDs) are one of the most prevalent clinical features described in individuals diagnosed with 22q11.2 deletion syndrome (22q11.2DS). Therefore, cardiac malformations may be the main finding to refer for syndrome investigation, especially in individuals with a mild phenotype. Nowadays, different cytogenetic methodologies have emerged and are used routinely in research laboratories. Hence, choosing an efficient technology and providing an accurate interpretation of clinical findings is crucial for 22q11.2DS patient's diagnosis.

This systematic review provides an update of the last 20 years of research on 22q11.2DS patients with CHD and the investigation process behind each diagnosis. A search was performed in PubMed, Embase, and LILACS using all entry terms to DiGeorge syndrome, CHDs, and cytogenetic analysis. After screening, 60 papers were eligible for review. We present a new insight of ventricular septal defect as a possible pivotal cardiac finding in individuals with 22q11.2DS. Also, we describe molecular technologies and cardiac evaluation as valuable tools in order to guide researchers in future investigations.

Keywords

22q11.2 deletion syndrome - congenital heart defects - DiGeorge syndrome - ventricular heart septal defects

Ethical Approval

This study did not require ethical approval.

Publication History

Received: 30 April 2021

Accepted: 16 January 2023

Article published online:
17 February 2023

• References

• 1 Shprintzen RJ. Velo-cardio-facial syndrome: 30 years of study. Dev Disabil Res Rev 2008; 14 (01) 3-10
• 2 Morrow BE, McDonald-McGinn DM, Emanuel BS, Vermeesch JR, Scambler PJ. Molecular genetics of 22q11.2 deletion syndrome. Am J Med Genet A 2018; 176 (10) 2070-2081
• 3 Goldmuntz E. 22q11.2 deletion syndrome and congenital heart disease. Am J Med Genet C Semin Med Genet 2020; 184 (01) 64-72
• 4 McDonald-McGinn DM, Sullivan KE, Marino B. et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers 2015; 1: 15071
• 5 Swillen A, McDonald-McGinn D. Developmental trajectories in 22q11.2 deletion. Am J Med Genet C Semin Med Genet 2015; 169 (02) 172-181
• 6 Mastroiacovo P, Rossi P, Cancrini C. et al. Chromosome 22q.11 deletion: recommendations for diagnosis and treatment. Italian Primary Immunodeficiencies Strategic Scientific Committee; 2005. Accessed November 25, 2020, at: http://www.aieop.org/stdoc/prot/rec_del22_en_06.pdf
• 7 Mutlu ET, Aykan HH, Karagöz T. Analysis of gene copy number variations in patients with congenital heart disease using multiplex ligation-dependent probe amplification. Anatol J Cardiol 2018; 20 (01) 9-15
• 8 Zhang J, Ma D, Wang Y. et al. Analysis of chromosome 22q11 copy number variations by multiplex ligation-dependent probe amplification for prenatal diagnosis of congenital heart defect. Mol Cytogenet 2015; 8: 100
• 9 Peng R, Xie HN, Zheng J, Zhou Y, Lin MF. Fetal right aortic arch: associated anomalies, genetic anomalies with chromosomal microarray analysis, and postnatal outcome. Prenat Diagn 2017; 37 (04) 329-335 [published correction appears in Prenat Diagn. 2018 Mar;38(4):298]
• 10 Chen CP, Huang JP, Chen YY. et al. Chromosome 22q11.2 deletion syndrome: prenatal diagnosis, array comparative genomic hybridization characterization using uncultured amniocytes and literature review. Gene 2013; 527 (01) 405-409
• 11 Fu F, Deng Q, Lei TY. et al. Clinical application of SNP array analysis in fetuses with ventricular septal defects and normal karyotypes. Arch Gynecol Obstet 2017; 296 (05) 929-940
• 12 Mcconnell ME. Tetralogy of Fallot. In: Garfunkel LC, Kaczorowski JM, Christy C. eds. Pediatric Clinical Advisor. 2nd ed. Missouri, United States: Mosby; 2007. :557
• 13 Snider P, Conway JS. Probing human cardiovascular congenital disease using transgenic mouse models. In: Chang KT, Min K-T. eds. Progress in Molecular Biology and Translational Science. Massachusetts, United States: Academic Press; 2011: 83-110
• 14 Jaouadi A, Tabebi M, Abdelhedi F. et al. A novel TBX1 missense mutation in patients with syndromic congenital heart defects. Biochem Biophys Res Commun 2018; 499 (03) 563-569
• 15 Chen M, Yang YS, Shih JC. et al. Microdeletions/duplications involving TBX1 gene in fetuses with conotruncal heart defects which are negative for 22q11.2 deletion on fluorescence in-situ hybridization. Ultrasound Obstet Gynecol 2014; 43 (04) 396-403
• 16 Rauch A, Hofbeck M, Cesnjevar R. et al. Search for somatic 22q11.2 deletions in patients with conotruncal heart defects. Am J Med Genet A 2004; 124A [phone]
• 17 Iascone MR, Vittorini S, Sacchelli M, Spadoni I, Simi P, Giusti S. Molecular characterization of 22q11 deletion in a three-generation family with maternal transmission. Am J Med Genet 2002; 108 (04) 319-321
• 18 Vittorini S, Sacchelli M, Iascone MR. et al. Molecular characterization of chromosome 22 deletions by short tandem repeat polymorphism (STRP) in patients with conotruncal heart defects. Clin Chem Lab Med 2001; 39 (12) 1249-1258
• 19 Pires R, Pires LM, Vaz SO. et al. Screening of copy number variants in the 22q11.2 region of congenital heart disease patients from the São Miguel Island, Azores, revealed the second patient with a triplication. BMC Genet 2014; 15: 115
• 20 Kuo YL, Chen CP, Wang LK. et al. Prenatal diagnosis and molecular cytogenetic characterization of chromosome 22q11.2 deletion syndrome associated with congenital heart defects. Taiwan J Obstet Gynecol 2014; 53 (02) 248-251
• 21 Gao W, Higaki T, Eguchi-Ishimae M. et al. DGCR6 at the proximal part of the DiGeorge critical region is involved in conotruncal heart defects. Hum Genome Var 2015; 2: 15004
• 22 Beaujard MP, Chantot S, Dubois M. et al. Atypical deletion of 22q11.2: detection using the FISH TBX1 probe and molecular characterization with high-density SNP arrays. Eur J Med Genet 2009; 52 (05) 321-327
• 23 Garavelli L, Rosato S, Wischmeijer A. et al. 22q11.2 distal deletion syndrome: description of a new case with truncus arteriosus type 2 and review. Mol Syndromol 2011; 2 (01) 35-44
• 24 Athanasiadis DI, Mylonas KS, Kasparian K. et al. Surgical outcomes in syndromic tetralogy of Fallot: a systematic review and evidence quality assessment. Pediatr Cardiol 2019; 40 (06) 1105-1112
• 25 Penny DJ, Vick III GW. Ventricular septal defect. Lancet 2011; 377 (9771): 1103-1112
• 26 Ryan AK, Goodship JA, Wilson DI. et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997; 34 (10) 798-804
• 27 Botto LD, May K, Fernhoff PM. et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003; 112 (1 Pt 1): 101-107
• 28 Kaul S. The interventricular septum in health and disease. Am Heart J 1986; 112 (03) 568-581
• 29 Liu Y, Chen S, Zühlke L. et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol 2019; 48 (02) 455-463
• 30 Downing TE, Kim YY. Tetralogy of Fallot: general principles of management. Cardiol Clin 2015; 33 (04) 531-541 , vii–viii
• 31 Sandoval JP, Chaturvedi RR, Benson L. et al. Right ventricular outflow tract stenting in tetralogy of Fallot infants with risk factors for early primary repair. Circ Cardiovasc Interv 2016; 9 (12) e003979
• 32 Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30 (12) e57
• 33 Edelmann L, Hirschhorn K. Clinical utility of array CGH for the detection of chromosomal imbalances associated with mental retardation and multiple congenital anomalies. Ann N Y Acad Sci 2009; 1151: 157-166
• 34 Di Franco A, Ohmes LB, Gaudino M. et al. Serendipity and innovation: history and evolution of transthoracic echocardiography. J Thorac Dis 2017; 9 (Suppl. 04) S257-S263
• 35 McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 2011; 90 (01) 1-18
• 36 Carlson C, Sirotkin H, Pandita R. et al. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet 1997; 61 (03) 620-629
• 37 Sebat J, Lakshmi B, Troge J. et al. Large-scale copy number polymorphism in the human genome. Science 2004; 305 (5683): 525-528
• 38 Thienpont B, Mertens L, de Ravel T. et al. Submicroscopic chromosomal imbalances detected by array-CGH are a frequent cause of congenital heart defects in selected patients. Eur Heart J 2007; 28 (22) 2778-2784
• 39 Southard AE, Edelmann LJ, Gelb BD. Role of copy number variants in structural birth defects. Pediatrics 2012; 129 (04) 755-763
• 40 Choi BG, Hwang SK, Kwon JE, Kim YH. Array comparative genomic hybridization as the first-line investigation for neonates with congenital heart disease: experience in a single tertiary center. Korean Circ J 2018; 48 (03) 209-216
• 41 Nagy O, Szakszon K, Biró BO. et al. Copy number variants detection by microarray and multiplex ligation-dependent probe amplification in congenital heart diseases. J Biotechnol 2019; 299: 86-95
• 42 Stuppia L, Antonucci I, Palka G, Gatta V. Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases. Int J Mol Sci 2012; 13 (03) 3245-3276
• 43 Monteiro RAC, de Freitas ML, Vianna GS. et al. Major contribution of genomic copy number variation in syndromic congenital heart disease: the use of MLPA as the first genetic test. Mol Syndromol 2017; 8 (05) 227-235
• 44 Sørensen KM, El-Segaier M, Fernlund E. et al. Screening of congenital heart disease patients using multiplex ligation-dependent probe amplification: early diagnosis of syndromic patients. Am J Med Genet A 2012; 158A [phone]
• 45 Fernández L, Nevado J, Santos F. et al. A deletion and a duplication in distal 22q11.2 deletion syndrome region. Clinical implications and review. BMC Med Genet 2009; 10: 48
• 46 Gunjan A, Paik J, Verreault A. Regulation of histone synthesis and nucleosome assembly. Biochimie 2005; 87 (07) 625-635
• 47 Arsham MS, Barch MJ, Lawce HJ. The AGT Cytogenetics Laboratory Manual. 4 ed. John Wiley & Sons; 2017
• 48 Pierpont ME, Basson CT, Benson Jr DW. et al; American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115 (23) 3015-3038